Goodwin (JD Supra South Africa)
-
Cipla to Open Biotech Facility in South Africa
Cipla has announced that it is investing 1.3 billion South African Rand (approximately 91 million USD) to open a biotech plant in South Africa. According to Cipla’s press release, this will be South Africa’s first state-of-the-art biotech manufacturing facility for the production of biosimilars. The facility will have the necessary design capacity and capabilities and will seek regulatory...
Request a trial to view additional results